You just read:

Tactiva Therapeutics to Present Positive Data on Novel Dual CD4/CD8 T Cell Receptor in Preclinical Models of Cancer at BioCentury's 24th Annual Newsmakers Conference

News provided by

Tactiva Therapeutics

Aug 31, 2017, 08:30 ET